TUESDAY, July 2, 2024 (HealthDay News) -- Ultrasound cannot reliably rule out endometrial cancer in Black women given how readings are now assessed, a new study argues. Transvaginal ultrasound is commonly used to screen for cancer by measuring the thickness of the endometrium, the inner wall of the uterus. This screening method is supposed to be 99% to 100% accurate for ruling out endometrial cancer, researchers said.
An endometrium thinner than 4 millimeters is considered normal; thicker readings typically trigger a biopsy to check for cancer. But that protocol can be deadly for Black women, study results show. Nearly 10% of Black women with endometrial cancer had thickness below 4 millimeters, researchers found by analyzing 1,500 Black patients who underwent hysterectomies at 10 hospitals.
“We found that 9.5% of the cancers in Black women were detected below the threshold of 4 millimeters, and 11.5% of the cancers would have been missed at 5 millimeters,” lead researcher Dr.
Kemi Doll , a gynecologic oncologist at the University of Washington, said in a news release. “This is just not acceptable,” Doll said of the current standards for ultrasound screening. “What we found in real-world clinical scenarios, is that it’s just not accurate enough to be safely employed as a strategy among Black people.
Whereas, a tissue biopsy is conclusive.” In an ultrasound screening, a probe is inserted into the vagina that produces sound waves. By moving it around, technicians .
